New lotion for Kids' psoriasis under the microscope

NCT ID NCT03988439

Completed Symptom relief Sponsor: Bausch Health Americas, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how a prescription lotion (IDP-118) works in children aged 4 to 16 with moderate to severe plaque psoriasis. Researchers measured how much of the drug enters the bloodstream and whether it affects the body's stress hormone system (HPA axis). The goal was to check safety and absorption, not to cure the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS

Contacts and locations

Locations

Bausch Site 1

Henderson, Nevada, 89052, United States
Bausch Site 11

Miami, Florida, 33173, United States
Bausch Site 12

Santo Domingo, Dominican Republic
Bausch Site 2

Panama City, Panama
Bausch Site 3

Louisville, Kentucky, 40217, United States
Bausch Site 4

Murray, Utah, 84123, United States
Bausch Site 5

San Antonio, Texas, 78213, United States
Bausch Site 6

Saint Joseph, Missouri, 64506, United States
Bausch Site 7

Doral, Florida, 33166, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.